108 related articles for article (PubMed ID: 38497538)
1. ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation.
Chan ICC; Panchot A; Schmidt E; McNulty S; Wiley BJ; Liu J; Turner K; Moukarzel L; Wong WSW; Tran D; Beeler JS; Batchi-Bouyou AL; Machiela MJ; Karyadi DM; Krajacich BJ; Zhao J; Kruglyak S; Lajoie B; Levy S; Patel M; Kantoff PW; Mason CE; Link DC; Druley TE; Stopsack KH; Bolton KL
Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38485690
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Genovese G; Kähler AK; Handsaker RE; Lindberg J; Rose SA; Bakhoum SF; Chambert K; Mick E; Neale BM; Fromer M; Purcell SM; Svantesson O; Landén M; Höglund M; Lehmann S; Gabriel SB; Moran JL; Lander ES; Sullivan PF; Sklar P; Grönberg H; Hultman CM; McCarroll SA
N Engl J Med; 2014 Dec; 371(26):2477-87. PubMed ID: 25426838
[TBL] [Abstract][Full Text] [Related]
3. Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older Adults.
Saadatagah S; Uddin MM; Weeks LD; Niroula A; Ru M; Takahashi K; Gondek L; Yu B; Bick AG; Ebert BL; Platz EA; Natarajan P; Ballantyne CM
JAMA Netw Open; 2024 Jan; 7(1):e2351927. PubMed ID: 38231513
[TBL] [Abstract][Full Text] [Related]
4. Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.
Rodriguez J; Baldini C; Bayle A; Pages A; Danlos FX; Vasseur D; Rouleau E; Lacroix L; Alonso de Castro B; Goldschmidt V; Seknazi L; Hollebecque A; Michot JM; Champiat S; Marabelle A; Ouali K; Marzac C; Ponce S; Micol JB; Chaput N; Massard C; Italiano A
JCO Precis Oncol; 2024 May; 8():e2300631. PubMed ID: 38815178
[TBL] [Abstract][Full Text] [Related]
5. Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
Marchetti A; Pelusi S; Marella A; Malvestiti F; Ricchiuti A; Ronzoni L; Lionetti M; Moretti V; Bugianesi E; Miele L; Vespasiani-Gentilucci U; Dongiovanni P; Federico A; Soardo G; D'Ambrosio R; McCain MV; Reeves HL; La Mura V; Prati D; Bolli N; Valenti L;
Hepatology; 2024 Mar; ():. PubMed ID: 38470216
[TBL] [Abstract][Full Text] [Related]
6. Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank.
Vlasschaert C; Akwo E; Robinson-Cohen C; Cook EK; Lanktree MB; Rauh MJ; Bick AG
Leukemia; 2023 Nov; 37(11):2306-2308. PubMed ID: 37689824
[No Abstract] [Full Text] [Related]
7. The impact of obesity-induced inflammation on clonal hematopoiesis.
Pasupuleti SK; Kapur R
Curr Opin Hematol; 2024 Jul; 31(4):193-198. PubMed ID: 38640133
[TBL] [Abstract][Full Text] [Related]
8. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes.
Nead KT; Kim T; Joo L; McDowell T; Wong J; Chan IC; Brock E; Zhao J; Xu T; Tang C; Lee CL; Abe JI; Bolton KL; Liao Z; Scheet P; Lin SH
Blood Adv; 2024 Jun; ():. PubMed ID: 38830141
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis of indeterminate potential as a prognostic factor: A systematic review and meta-analysis.
Singh J; Li NY; Ashrafi E; Thao LTP; Curtis DJ; Wood EM; McQuilten Z
Blood Adv; 2024 Jun; ():. PubMed ID: 38838228
[TBL] [Abstract][Full Text] [Related]
10. Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis.
Bernstein N; Spencer Chapman M; Nyamondo K; Chen Z; Williams N; Mitchell E; Campbell PJ; Cohen RL; Nangalia J
Nat Genet; 2024 May; ():. PubMed ID: 38744975
[TBL] [Abstract][Full Text] [Related]
11. CHIPing away at proteomics to find correlations with myeloid neoplasms.
Bhalgat AM; Taylor J
Clin Cancer Res; 2024 May; ():. PubMed ID: 38819216
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis of indeterminate potential and risk of hepatocellular carcinoma: New kids on the block.
Lee YT; Tseng HR; Yang JD
Hepatology; 2024 Apr; ():. PubMed ID: 38640021
[No Abstract] [Full Text] [Related]
13. Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer.
Arends CM; Kopp K; Hablesreiter R; Estrada N; Christen F; Moll UM; Zeillinger R; Schmitt WD; Sehouli J; Kulbe H; Fleischmann M; Ray-Coquard I; Zeimet A; Raspagliesi F; Zamagni C; Vergote I; Lorusso D; Concin N; Bullinger L; Braicu EI; Damm F
Leukemia; 2024 Jun; 38(6):1440. PubMed ID: 38714878
[No Abstract] [Full Text] [Related]
14. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
[TBL] [Abstract][Full Text] [Related]
15. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
Younes IE; Syler L; Hamed A
Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
[TBL] [Abstract][Full Text] [Related]
16. Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis.
Karner K; George TI; Patel JL
Ann Lab Med; 2019 Nov; 39(6):509-514. PubMed ID: 31240877
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm.
Gaulin C; Kelemen K; Arana Yi C
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013314
[TBL] [Abstract][Full Text] [Related]
18. Clonal Hematopoiesis: Origins and determinants of evolution.
Mendez LM; Patnaik MM
Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
Osman A; Patel JL
Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
